Parameters | OS | PFS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Clinical parameters | Â | Â | Â | |||
Age (years) | 0.986 | 0.958–1.016 | 0.361 | 0.985 | 0.956–1.015 | 0.328 |
Sex | Â | Â | Â | Â | Â | Â |
 Male | 1 |  |  | 1 |  |  |
 Female | 0.821 | 0.255–2.642 | 0.741 | 0.763 | 0.238–2.451 | 0.650 |
Histologic differentiation grade | Â | 0.964 | Â | 0.988 | Â | |
 Poor | 1 |  |  | 1 |  |  |
 Moderate | 0.956 | 0.648–1.412 | 0.822 | 0.977 | 0.581–1.643 | 0.931 |
 Well | 1.025 | 0.701–1.499 | 0.898 | 0.935 | 0.383–2.287 | 0.884 |
Tumor location | Â | 0.006 | Â | 0.011 | Â | |
 Upper | 1 |  |  | 1 |  |  |
 Middle | 1.450 | 0.804–2.616 | 0.217 | 1.333 | 0.739–2.402 | 0.340 |
 Lower | 2.892 | 1.491–5.612 | 0.002 | 2.654 | 1.375–5.122 | 0.004 |
Clinical T stage | Â | 0.165 | Â | 0.082 | Â | |
 T1 | 1 |  |  | 1 |  |  |
 T2 | 1.027 | 0.417–2.528 | 0.954 | 1.006 | 0.409–2.476 | 0.989 |
 T3 | 2.050 | 0.851–4.939 | 0.109 | 2.163 | 0.894–5.236 | 0.087 |
 T4 | 1.611 | 0.691–3.759 | 0.270 | 1.857 | 0.792–4.353 | 0.154 |
Clinical N stage | Â | 0.824 | Â | 0.896 | Â | |
 N1 | 1 |  |  | 1 |  |  |
 N2 | 1.027 | 0.580–1.820 | 0.927 | 0.901 | 0.506–1.602 | 0.722 |
 N3 | 1.252 | 0.588–2.665 | 0.560 | 1.034 | 0.487–2.196 | 0.930 |
AJCC Stage | Â | Â | Â | Â | Â | |
 I–III | 1 |  |  | 1 |  |  |
 IV | 1.310 | 0.801–2.142 | 0.283 | 1.366 | 0.835–2.235 | 0.214 |
Chemotherapy | Â | Â | Â | Â | Â | |
 Yes | 1 |  |  | 1 |  |  |
 No | 1.267 | 0.644–2.493 | 0.492 | 1.294 | 0.658–2.544 | 0.456 |
PET parameters | Â | Â | Â | Â | Â | |
SUVTumor | 1.043 | 0.999–1.089 | 0.055 | 1.054 | 1.009–1.101 | 0.019 |
MTV (cm3) | 1.022 | 1.011–1.033 |  < 0.001 | 1.02 | 1.01–1.031 |  < 0.001 |
TLG (g) | 1.002 | 1.001–1.004 |  < 0.001 | 1.002 | 1.001–1.003 |  < 0.001 |
SUVLN | 1.025 | 0.993–1.057 | 0.129 | 1.025 | 0.993–1.057 | 0.121 |
PLNS number | 1.063 | 0.993–1.138 | 0.081 | 1.037 | 0.968–1.110 | 0.304 |
SDmax(LN-T)(m−1) | 6.516 | 2.427–17.499 |  < 0.001 | 4.972 | 1.798–13.746 | 0.002 |